Skip to main content
Top
Gepubliceerd in:

03-01-2019

Comparison of quality of life measurements: EQ-5D-5L versus disease/treatment-specific measures in pulmonary embolism and deep vein thrombosis

Auteurs: Ling-Hsiang Chuang, Alexander T. Cohen, Giancarlo Agnelli, Pearl D. Gumbs, Rupert Bauersachs, Sonja Kroep, Anselm K. Gitt, Manuel Monreal, Stefan N. Willich, Ben van Hout

Gepubliceerd in: Quality of Life Research | Uitgave 5/2019

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Introduction

There is a lack of performance comparisons of the generic quality of life tool EQ-5D-5L against disease- and treatment-specific measures in venous thromboembolism (VTE). The aim of this study was to compare EQ-5D-5L against the pulmonary embolism (PE)-specific PEmb-QoL and the deep vein thrombosis (DVT)-specific VEINES-QOL/Sym, and PACT-Q2 (treatment-specific) questionnaires in five language settings.

Methods

PREFER in VTE was a non-interventional disease registry conducted between 2013 and 2014 in primary and secondary care across seven European countries with five languages, including English, French, German, Italian and Spanish. Consecutive patients with acute PE/DVT were enrolled and followed over 12 months. Only patients who completed all three questionnaires at baseline were included in the study sample. The psychometric properties examined included acceptability (missing, ceiling and floor effects), validity (convergent and known-groups validity), and responsiveness. Known groups validity and responsiveness were assessed using both effect size (Cohen’s d) and relative efficiency (F-statistic). All analyses were conducted in each language version and the total sample across all languages.

Results

A total of 1054 PE and 1537 DVT patients were included. 14% of PE and 10% of DVT patients had the maximum EQ-5D-5L index score. EQ-5D-5L was low to moderately correlated with other measures (r < 0.5). EQ-5D-5L was associated with larger effect size/relative efficiency in most of known group comparisons in both VTE groups. Similar results were observed for responsiveness. EQ-5D-5L performed relatively better in French, Italian and Spanish language versions.

Conclusion

Overall EQ-5D-5L is comparable to PEmb-QoL, VEINES-QOL/Sym and PACT-Q2 in terms of acceptability, validity and responsiveness in both PE and DVT populations in English, French, German, Italian and Spanish language version. Nevertheless, it should be noted that each measure is designed to capture different aspects of health-related quality of life.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
1.
go back to reference Brook, R. (1996). EuroQol: The current state of play. Health Policy, 37, 53–72.CrossRef Brook, R. (1996). EuroQol: The current state of play. Health Policy, 37, 53–72.CrossRef
2.
go back to reference Janssen, M. F., Birnie, E., & Bonsel, G. J. (2008). Quantification of the level descriptors for the standard EQ-5D three-level system and a five level version according to two methods. Quality of Life Research, 17(3), 463–473.CrossRefPubMedPubMedCentral Janssen, M. F., Birnie, E., & Bonsel, G. J. (2008). Quantification of the level descriptors for the standard EQ-5D three-level system and a five level version according to two methods. Quality of Life Research, 17(3), 463–473.CrossRefPubMedPubMedCentral
3.
go back to reference Janssen, M. F., Birnie, E., Haagsma, J. A., & Bonsel, G. J. (2008). Comparing the standard EQ-5D three-level system with a five-level version. Value Health, 11(2), 275–284.CrossRefPubMed Janssen, M. F., Birnie, E., Haagsma, J. A., & Bonsel, G. J. (2008). Comparing the standard EQ-5D three-level system with a five-level version. Value Health, 11(2), 275–284.CrossRefPubMed
4.
go back to reference Sullivan, P. W., & Ghushchyan, V. (2006). Preference-based EQ-5D index scores for chronic conditions in the United States. Medical Decision Making, 26(4), 410–420.CrossRefPubMedPubMedCentral Sullivan, P. W., & Ghushchyan, V. (2006). Preference-based EQ-5D index scores for chronic conditions in the United States. Medical Decision Making, 26(4), 410–420.CrossRefPubMedPubMedCentral
5.
go back to reference Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., Bonsel, G., & Badia, X. (2011). Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research, 20(10), 1727–1736.CrossRefPubMedPubMedCentral Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., Bonsel, G., & Badia, X. (2011). Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research, 20(10), 1727–1736.CrossRefPubMedPubMedCentral
6.
go back to reference Pickard, A. S., De Leon, M. C., Kohlmann, T., Cella, D., & Rosenbloom, S. (2007). Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients. Medical Care, 45(3), 259–263.CrossRefPubMed Pickard, A. S., De Leon, M. C., Kohlmann, T., Cella, D., & Rosenbloom, S. (2007). Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients. Medical Care, 45(3), 259–263.CrossRefPubMed
7.
go back to reference Kim, S. H., Kim, H. J., Lee, S. I., & Jo, M. W. (2012). Comparing the psychometry properties of the EQ-5D-3L and EQ-5D-5L in cancer patients in Korea. Quality of Life Research, 21(6), 1065–1073.CrossRefPubMed Kim, S. H., Kim, H. J., Lee, S. I., & Jo, M. W. (2012). Comparing the psychometry properties of the EQ-5D-3L and EQ-5D-5L in cancer patients in Korea. Quality of Life Research, 21(6), 1065–1073.CrossRefPubMed
8.
go back to reference Agborsangaya, C. B., Lahtinen, M., Cooke, T., & Johnson, J. A. (2014). Comparing the EQ-5D 3L and 5L: Measurement properties and association with chronic conditions and multimorbidity in the general population. Health and Quality of Life Outcomes, 12, 74.CrossRefPubMedPubMedCentral Agborsangaya, C. B., Lahtinen, M., Cooke, T., & Johnson, J. A. (2014). Comparing the EQ-5D 3L and 5L: Measurement properties and association with chronic conditions and multimorbidity in the general population. Health and Quality of Life Outcomes, 12, 74.CrossRefPubMedPubMedCentral
9.
go back to reference Kim, T. H., Jo, M. W., Lee, S. I., Kim, S. H., & Chung, S. M. (2013). Psychometric properties of the EQ-5D-5L in the general population of South Korea. Quality of Life Research, 22, 2245–2253.CrossRefPubMed Kim, T. H., Jo, M. W., Lee, S. I., Kim, S. H., & Chung, S. M. (2013). Psychometric properties of the EQ-5D-5L in the general population of South Korea. Quality of Life Research, 22, 2245–2253.CrossRefPubMed
10.
go back to reference Hinz, A., Kohlmann, T., Stobel-Rochter, Y., Zenger, M., & Brahler, E. (2014). The quality of life questionnaire EQ-5D-5L: Psychometric properties and normative values for the general German population. Quality of Life Research, 23, 443–447.CrossRefPubMed Hinz, A., Kohlmann, T., Stobel-Rochter, Y., Zenger, M., & Brahler, E. (2014). The quality of life questionnaire EQ-5D-5L: Psychometric properties and normative values for the general German population. Quality of Life Research, 23, 443–447.CrossRefPubMed
11.
go back to reference Scalone, L., Coampichini, R., Fagiouli, S., Gardini, I., Fusco, F., Gaeta, L., et al. (2013). Comparing the performance of the standard EQ-5D-3L with the new version EQ-5D-5L in patients with chronic hepatic diseases. Quality of Life Research, 22, 1707–1716.CrossRefPubMed Scalone, L., Coampichini, R., Fagiouli, S., Gardini, I., Fusco, F., Gaeta, L., et al. (2013). Comparing the performance of the standard EQ-5D-3L with the new version EQ-5D-5L in patients with chronic hepatic diseases. Quality of Life Research, 22, 1707–1716.CrossRefPubMed
13.
go back to reference Golicki, D., Niewada, M., Buczek, J., Karlinska, A., Kobayashi, A., Janssen, M. F., et al. (2015). Validity of EQ-5D-5L in stroke. Quality of Life Research, 24, 845–850.CrossRefPubMed Golicki, D., Niewada, M., Buczek, J., Karlinska, A., Kobayashi, A., Janssen, M. F., et al. (2015). Validity of EQ-5D-5L in stroke. Quality of Life Research, 24, 845–850.CrossRefPubMed
14.
go back to reference Garcia-Gordillo, M. A., Pozo-Cruz, B. D., Adsuar, J. C., Sanchez- Martinez, F. I., & Abelian-Perpinan, J. M. (2014). Validation and comparison of the 15-D and EQ-5D-5L instruments in a Spanish Parkinson’s disease population sample. Quality of Life Research, 23, 1315–1326.CrossRefPubMed Garcia-Gordillo, M. A., Pozo-Cruz, B. D., Adsuar, J. C., Sanchez- Martinez, F. I., & Abelian-Perpinan, J. M. (2014). Validation and comparison of the 15-D and EQ-5D-5L instruments in a Spanish Parkinson’s disease population sample. Quality of Life Research, 23, 1315–1326.CrossRefPubMed
15.
go back to reference Tran, B. X., Ohinmaa, A., & Nguyen, L. T. (2012). Quality of life profile and psychometric properties of the EQ-5D-5L in HIV/AIDS patients. Health and Quality of life Outcomes, 10, 132.CrossRefPubMedPubMedCentral Tran, B. X., Ohinmaa, A., & Nguyen, L. T. (2012). Quality of life profile and psychometric properties of the EQ-5D-5L in HIV/AIDS patients. Health and Quality of life Outcomes, 10, 132.CrossRefPubMedPubMedCentral
16.
go back to reference Agnelli, G., Gitt, A. K., Bauersachs, R., Fronk, E., Laeis, P., Mismetti, P., Monreal, M., Willich, S. N., Wolf, W., & Cohen, A. T. and on behalf of the PREFER in VTE investigators. (2015). The management of acute venous thromboembolism in clinical practice—study rationale and protocol of the European PREFER in VTE registry. Thrombosis Journal, 13, 41.CrossRefPubMedPubMedCentral Agnelli, G., Gitt, A. K., Bauersachs, R., Fronk, E., Laeis, P., Mismetti, P., Monreal, M., Willich, S. N., Wolf, W., & Cohen, A. T. and on behalf of the PREFER in VTE investigators. (2015). The management of acute venous thromboembolism in clinical practice—study rationale and protocol of the European PREFER in VTE registry. Thrombosis Journal, 13, 41.CrossRefPubMedPubMedCentral
17.
go back to reference Cohen, A. T., et al. (2017). The management of acute venous thromboembolism in clinical practice. Results from the European PREFER in VTE Registry. Thrombosis and Haemostasis, 117, 1326–1337.CrossRefPubMedPubMedCentral Cohen, A. T., et al. (2017). The management of acute venous thromboembolism in clinical practice. Results from the European PREFER in VTE Registry. Thrombosis and Haemostasis, 117, 1326–1337.CrossRefPubMedPubMedCentral
18.
go back to reference Devlin, N., Shah, K., Feng, Y., Mulhern, B., & Van Hout, B. (2018). Valuing health-related quality of life: An EQ-5D-5L value set for England. Health Economics, 27(1), 7–22.CrossRefPubMed Devlin, N., Shah, K., Feng, Y., Mulhern, B., & Van Hout, B. (2018). Valuing health-related quality of life: An EQ-5D-5L value set for England. Health Economics, 27(1), 7–22.CrossRefPubMed
19.
go back to reference Klok, F. A., Cohn, D. M., Middeldorp, S., Scharloo, M., Bu¨ ller H. R., van Kralingen, K. W., Kaptein, A. A., & Huisman, M. V. (2010). Quality of life after pulmonary embolism: Validation of the PEmb-QoL Questionnaire. Journal of Thrombosis and Haemostasis, 8, 523–532.CrossRefPubMed Klok, F. A., Cohn, D. M., Middeldorp, S., Scharloo, M., Bu¨ ller H. R., van Kralingen, K. W., Kaptein, A. A., & Huisman, M. V. (2010). Quality of life after pulmonary embolism: Validation of the PEmb-QoL Questionnaire. Journal of Thrombosis and Haemostasis, 8, 523–532.CrossRefPubMed
20.
go back to reference Kahn, S. R., Lampingc, D. L., Ducrueta, T., Arsenaulta, L., Mirond, M. J., Roussind, A., Desmaraise, S., Joyald, F., Kassisd, J., Solymossb, S., Desjardinsf, L., & Johria, M., Shrier I., for the VETO Study investigators. (2006). VEINES-QOL/Sym questionnaire was a reliable and valid disease specific quality of life measure for deep venous thrombosis. Journal of Clinical Epidemiology, 59, 1049–1056.PubMed Kahn, S. R., Lampingc, D. L., Ducrueta, T., Arsenaulta, L., Mirond, M. J., Roussind, A., Desmaraise, S., Joyald, F., Kassisd, J., Solymossb, S., Desjardinsf, L., & Johria, M., Shrier I., for the VETO Study investigators. (2006). VEINES-QOL/Sym questionnaire was a reliable and valid disease specific quality of life measure for deep venous thrombosis. Journal of Clinical Epidemiology, 59, 1049–1056.PubMed
21.
go back to reference Prins, M. H., Guillemin, I., Gilet, H., Gabriel, S., Essers, B., & Raskob, G. and SR Kahn. (2009). Scoring and psychometric validation of the Perception of Anticoagulant Treatment Questionnaire (PACT-Q©). Health and Quality of Life Outcomes, 7, 30.CrossRefPubMedPubMedCentral Prins, M. H., Guillemin, I., Gilet, H., Gabriel, S., Essers, B., & Raskob, G. and SR Kahn. (2009). Scoring and psychometric validation of the Perception of Anticoagulant Treatment Questionnaire (PACT-Q©). Health and Quality of Life Outcomes, 7, 30.CrossRefPubMedPubMedCentral
22.
go back to reference Fayers, P. M., M, D (2007). Quality of life: The assessment, analysis and interpretation of patient-reported outcomes (2nd edn.). Chichester: John Wiley & Sons Ltd.CrossRef Fayers, P. M., M, D (2007). Quality of life: The assessment, analysis and interpretation of patient-reported outcomes (2nd edn.). Chichester: John Wiley & Sons Ltd.CrossRef
23.
go back to reference Yang, F., Lau, T., Lee, E., Vathsala, A., Chia, K. S., & Luo, N. (2015). Comparison of the preference-based EQ-5D-5L and SF-6D in patients with end-stage renal disease (ESRD). The European Journal of Health Economics, 16, 1019–1026.CrossRefPubMed Yang, F., Lau, T., Lee, E., Vathsala, A., Chia, K. S., & Luo, N. (2015). Comparison of the preference-based EQ-5D-5L and SF-6D in patients with end-stage renal disease (ESRD). The European Journal of Health Economics, 16, 1019–1026.CrossRefPubMed
24.
go back to reference Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd edn.). Hillsdale: Lawrence Erlbaum Associates. Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd edn.). Hillsdale: Lawrence Erlbaum Associates.
25.
go back to reference Tavoly, M., Utne, K. K., Jelsness-Jørgensen, L.-P., et al. (2016). Health-related quality of life after pulmonary embolism: A cross-sectional study. British Medical Journal Open, 6, e013086. Tavoly, M., Utne, K. K., Jelsness-Jørgensen, L.-P., et al. (2016). Health-related quality of life after pulmonary embolism: A cross-sectional study. British Medical Journal Open, 6, e013086.
26.
go back to reference Brazier, J., Ratcilffe, J., Salomon, A., & Tsuchiya, A. (2007). Measuring and valuing health benefits for economic evaluation (2nd edn.). Oxford: Oxford University Press. Brazier, J., Ratcilffe, J., Salomon, A., & Tsuchiya, A. (2007). Measuring and valuing health benefits for economic evaluation (2nd edn.). Oxford: Oxford University Press.
Metagegevens
Titel
Comparison of quality of life measurements: EQ-5D-5L versus disease/treatment-specific measures in pulmonary embolism and deep vein thrombosis
Auteurs
Ling-Hsiang Chuang
Alexander T. Cohen
Giancarlo Agnelli
Pearl D. Gumbs
Rupert Bauersachs
Sonja Kroep
Anselm K. Gitt
Manuel Monreal
Stefan N. Willich
Ben van Hout
Publicatiedatum
03-01-2019
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 5/2019
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-018-2081-3